Koers SanBio Company Limited OTC Markets
Aandelen
SNBOY
US7995731004
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,81 USD | -48,72% | 0,00% | 0,00% |
19/03 | SANBIO COMPANY LIMITED : Jefferies & Co. behoudt het verkoopadvies | ZM |
19/03 | Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024 |
Omzet 2024 | - | Omzet 2025 * | - | Marktkapitalisatie | 28,76 mld. 182 mln. 170 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | -2,64 mld. -16,69 mln. -15,62 mln. | Nettowinst (verlies) 2025 * | -3,3 mld. -20,8 mln. -19,46 mln. | EV/omzet 2024 | - |
Nettoliquiditeiten 2024 * | 5,65 mld. 35,64 mln. 33,34 mln. | Nettoschuld 2025 * | 226 mln. 1,43 mln. 1,33 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 |
-14
x | K/w-verhouding 2025 * |
-8,54
x | Werknemers | 65 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 71,15% |
Recentste transcriptie over SanBio Company Limited
1 dag | -48,72% | ||
Lopende maand | -48,72% | ||
1 maand | -48,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 27-02-13 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 01-03-13 |
Keita Mori
CEO | Chief Executive Officer | 56 | 27-02-13 |
Toru Kawanishi
CHM | Chairman | 56 | 27-02-13 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers 4592
- Koers SNBOY